Thermo Fisher Scientific

Helping scientists answer questions that enable breakthrough discoveries in life sciences, materials science and industry

  • Categories
    • Accelerating Microscopy
    • Advancing Materials
    • Advancing Mining
    • Analyzing Metals
    • Ask a Scientist
    • Behind the Bench
    • Examining Food
    • Identifying Threats
    • Life in the Lab
    • The Connected Lab
  • About Us
  • Contact
Accelerating ScienceAccelerating Microscopy / General / Cryo-EM Drives Advances in Parkinson’s Disease Research

Cryo-EM Drives Advances in Parkinson’s Disease Research

By Bernhard Goetze 09.23.2020

Parkinson’s disease is a debilitating disorder that continues to impact millions, but there is still little known about the underlying mechanisms of the disease. However, recent work from the University of California San Diego has revealed critical details regarding a key protein linked to genetically inherited Parkinson’s disease, the leucine-rich repeat kinase 2 (LRRK2). While its ties to Parkinson’s have been known since the early 2000s, the mechanism and structure of LRRK2 have evaded researchers. Now, using both cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET), scientists from the Reck-Peterson, Leschziner, and Villa groups of UCSD were able to visualize the protein, both at high resolution and within its natural cellular environment. Future drugs designed to combat Parkinson’s would rely on this kind of fundamental information, including LRRK2’s structure, behavior, and function within the cell, to be effective.

LRRK2 protein model showing how it could block critical movement across the cell

Roadblock: This image depicts a model for how LRRK2 could block critical movement across the cell. The visualization shows a short LRRK2 filament (red, green and yellow) wrapped around a cellular track called a microtubule, forming a roadblock for the microtubule-based motors kinesin (light blue) and dynein (blue). (Photo credit: Leschziner Lab, UC San Diego)

Cryo EM and the Aligning Science Across Parkinson’s initiative

This work has prompted substantial investment from the Aligning Science Across Parkinson’s (ASAP) initiative, which has extended a $7.2 million grant to these laboratories, along with two others based in Germany. This funding, as well as the publication of these results in both Nature and Cell, underscores the vital importance of cryo-EM techniques for further expanding our general understanding of Parkinson’s disease pathology.

Thermo Fisher Scientific is honored to support this critical work through our cryo-EM instrumentation, and we look forward to seeing the future advances these groups make in the battle against Parkinson’s and other diseases.

To learn more about our cryo-EM instruments, please see our life sciences microscopy webpage.

Bernhard Goetze is director, product marketing at Thermo Fisher Scientific.

///

Subscribe now to receive Accelerating Microscopy updates straight to your inbox.

Speak with an expert: https://www.thermofisher.com/blog/microscopy/speak-with-an-expert/

Share this article


FacebookLinkedin
Storage pucks for cryo-EM grid boxes

New Pucks for Cryo-EM Grid Boxes to Simplify Sample Storage and Shipping

Cryo-EM sample preparation One of the challenges in cryo-EM ... by Edward Pryor / 04.14.2022

Read More
Cryo-EM tau protein structure studies unravel neurodegenerative disease mysteries

Advances in Cryo-EM Tau Protein Structure Studies Unravel Neurodegenerative Mysteries

From Alzheimer’s disease to dementia, neurodegenerative di... by Leah Lavery / 04.11.2022

Read More
epitope mapping of SARS-CoV-2 spike

Rapid Cryo-EM Epitope Mapping Could Enhance Antibody Drug Discovery

Historically, cryo-electron microscopy (cryo-EM) structure d... by Mazdak Radjainia / 02.24.2022

Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Four Factors Academic Labs Should Consider Before Investing in an SEM
Why Is Microanalysis So Slow?

Privacy StatementTerms & ConditionsLocationsSitemap

© 2022 Thermo Fisher Scientific. All Rights Reserved.

Talk to us